# Broadcom Inc.: financial statements, quarterly

AVGO · Nasdaq · CIK 1730168 · [Technology](/sectors/technology.md) · fiscal year ends Nov 1

Pages: [Overview](/companies/avgo.md) · [Financials](/companies/avgo/financials.md) · [Filings](/companies/avgo/filings.md) · [Insiders](/companies/avgo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/avgo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-29) | Q1 FY2024 (2024-02-04) | Q2 FY2024 (2024-05-05) | Q3 FY2024 (2024-08-04) | Q4 FY2024 (2024-11-03) | Q1 FY2025 (2025-02-02) | Q2 FY2025 (2025-05-04) | Q3 FY2025 (2025-08-03) | Q4 FY2025 (2025-11-02) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [9.3 d](/filings/0001730168-25-000121.md) | [12.0](/filings/0001730168-25-000021.md) | [12.5](/filings/0001730168-25-000064.md) | [13.1](/filings/0001730168-25-000098.md) | [14.1 d](/filings/0001730168-25-000121.md) | [14.9](/filings/0001730168-26-000016.md) | [15.0](/filings/0001730168-26-000054.md) | [16.0](/filings/0001730168-26-000080.md) | [18.0 d](/filings/0001730168-25-000121.md) | [19.3](/filings/0001730168-26-000016.md) | [22.2](/filings/0001730168-26-000054.md) | [29.6](/filings/0001730168-26-000080.md) |
| Cost of revenue | $bn | [2.9 d](/filings/0001730168-25-000121.md) | [4.6](/filings/0001730168-25-000021.md) | [4.7](/filings/0001730168-25-000064.md) | [4.7](/filings/0001730168-25-000098.md) | [5.1 d](/filings/0001730168-25-000121.md) | [4.8](/filings/0001730168-26-000016.md) | [4.8](/filings/0001730168-26-000054.md) | [5.2](/filings/0001730168-26-000080.md) | [5.8 d](/filings/0001730168-25-000121.md) | [6.2](/filings/0001730168-26-000016.md) | [6.8](/filings/0001730168-26-000054.md) | [9.1](/filings/0001730168-26-000080.md) |
| Gross profit | $bn | [6.4 d](/filings/0001730168-25-000121.md) | [7.4](/filings/0001730168-25-000021.md) | [7.8](/filings/0001730168-25-000064.md) | [8.4](/filings/0001730168-25-000098.md) | [9.0 d](/filings/0001730168-25-000121.md) | [10.1](/filings/0001730168-26-000016.md) | [10.2](/filings/0001730168-26-000054.md) | [10.7](/filings/0001730168-26-000080.md) | [12.2 d](/filings/0001730168-25-000121.md) | [13.2](/filings/0001730168-26-000016.md) | [15.4](/filings/0001730168-26-000054.md) | [20.5](/filings/0001730168-26-000080.md) |
| Research and development | $bn | [1.4 d](/filings/0001730168-25-000121.md) | [2.3](/filings/0001730168-25-000021.md) | [2.4](/filings/0001730168-25-000064.md) | [2.4](/filings/0001730168-25-000098.md) | [2.2 d](/filings/0001730168-25-000121.md) | [2.3](/filings/0001730168-26-000016.md) | [2.7](/filings/0001730168-26-000054.md) | [3.1](/filings/0001730168-26-000080.md) | [3.0 d](/filings/0001730168-25-000121.md) | [3.0](/filings/0001730168-26-000016.md) | [3.0](/filings/0001730168-26-000054.md) | [2.9](/filings/0001730168-26-000080.md) |
| Selling, general and administrative | $bn | [0.4 d](/filings/0001730168-25-000121.md) | [1.6](/filings/0001730168-25-000021.md) | [1.3](/filings/0001730168-25-000064.md) | [1.1](/filings/0001730168-25-000098.md) | [1.0 d](/filings/0001730168-25-000121.md) | [0.9](/filings/0001730168-26-000016.md) | [1.1](/filings/0001730168-26-000054.md) | [1.1](/filings/0001730168-26-000080.md) | [1.1 d](/filings/0001730168-25-000121.md) | [1.0](/filings/0001730168-26-000016.md) | [1.1](/filings/0001730168-26-000054.md) | [1.0](/filings/0001730168-26-000080.md) |
| Operating income | $bn | [4.2 d](/filings/0001730168-25-000121.md) | [2.1](/filings/0001730168-25-000021.md) | [3.0](/filings/0001730168-25-000064.md) | [3.8](/filings/0001730168-25-000098.md) | [4.6 d](/filings/0001730168-25-000121.md) | [6.3](/filings/0001730168-26-000016.md) | [5.8](/filings/0001730168-26-000054.md) | [5.9](/filings/0001730168-26-000080.md) | [7.5 d](/filings/0001730168-25-000121.md) | [8.6](/filings/0001730168-26-000016.md) | [10.8](/filings/0001730168-26-000054.md) | [16.0](/filings/0001730168-26-000080.md) |
| Interest expense | $bn | [0.4 d](/filings/0001730168-24-000139.md) | [0.9](/filings/0001730168-25-000021.md) | [1.0](/filings/0001730168-25-000064.md) | [1.1](/filings/0001730168-25-000098.md) | [0.9 d](/filings/0001730168-24-000139.md) | [0.9](/filings/0001730168-26-000016.md) | [0.8](/filings/0001730168-26-000054.md) | [0.8](/filings/0001730168-26-000080.md) | [0.8 d](/filings/0001730168-25-000121.md) | [0.8](/filings/0001730168-26-000016.md) | [0.8](/filings/0001730168-26-000054.md) | [0.8](/filings/0001730168-26-000080.md) |
| Income tax | $bn | [0.4 d](/filings/0001730168-25-000121.md) | [0.1](/filings/0001730168-25-000021.md) | [(0.1)](/filings/0001730168-25-000064.md) | [4.2](/filings/0001730168-25-000098.md) | [(0.4) d](/filings/0001730168-25-000121.md) | [(0.0)](/filings/0001730168-26-000016.md) | [0.1](/filings/0001730168-26-000054.md) | [1.1](/filings/0001730168-26-000080.md) | [(1.6) d](/filings/0001730168-25-000121.md) | [0.8](/filings/0001730168-26-000016.md) | [0.8](/filings/0001730168-26-000054.md) | [2.2](/filings/0001730168-26-000080.md) |
| Net income | $bn | [3.5 d](/filings/0001730168-24-000139.md) | [1.3](/filings/0001730168-25-000098.md) | [2.1](/filings/0001730168-25-000098.md) | [(1.9)](/filings/0001730168-25-000098.md) | [4.3 d](/filings/0001730168-24-000139.md) | [5.5](/filings/0001730168-26-000080.md) | [5.0](/filings/0001730168-26-000080.md) | [4.1](/filings/0001730168-26-000080.md) | [8.5 d](/filings/0001730168-25-000121.md) | [7.3](/filings/0001730168-26-000080.md) | [9.3](/filings/0001730168-26-000080.md) | [13.1](/filings/0001730168-26-000080.md) |
| Diluted EPS | $ per share | not reported | [0.28](/filings/0001730168-25-000021.md) | [0.44](/filings/0001730168-25-000064.md) | [(0.40)](/filings/0001730168-25-000098.md) | not reported | [1.14](/filings/0001730168-26-000016.md) | [1.03](/filings/0001730168-26-000054.md) | [0.85](/filings/0001730168-26-000080.md) | not reported | [1.50](/filings/0001730168-26-000016.md) | [1.91](/filings/0001730168-26-000054.md) | [2.68](/filings/0001730168-26-000080.md) |
| Basic EPS | $ per share | not reported | [0.29](/filings/0001730168-25-000021.md) | [0.46](/filings/0001730168-25-000064.md) | [(0.40)](/filings/0001730168-25-000098.md) | not reported | [1.17](/filings/0001730168-26-000016.md) | [1.05](/filings/0001730168-26-000054.md) | [0.88](/filings/0001730168-26-000080.md) | not reported | [1.55](/filings/0001730168-26-000016.md) | [1.96](/filings/0001730168-26-000054.md) | [2.75](/filings/0001730168-26-000080.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-29) | Q1 FY2024 (2024-02-04) | Q2 FY2024 (2024-05-05) | Q3 FY2024 (2024-08-04) | FY2024 (2024-11-03) | Q1 FY2025 (2025-02-02) | Q2 FY2025 (2025-05-04) | Q3 FY2025 (2025-08-03) | FY2025 (2025-11-02) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [14.2](/filings/0001730168-24-000139.md) | [11.9](/filings/0001730168-24-000023.md) | [9.8](/filings/0001730168-24-000080.md) | [10.0](/filings/0001730168-24-000099.md) | [9.3](/filings/0001730168-25-000121.md) | [9.3](/filings/0001730168-25-000021.md) | [9.5](/filings/0001730168-25-000064.md) | [10.7](/filings/0001730168-25-000098.md) | [16.2](/filings/0001730168-26-000080.md) | [14.2](/filings/0001730168-26-000016.md) | [19.6](/filings/0001730168-26-000054.md) | [24.0](/filings/0001730168-26-000080.md) |
| Current assets | $bn | [20.8](/filings/0001730168-24-000139.md) | [27.2](/filings/0001730168-24-000023.md) | [25.3](/filings/0001730168-24-000080.md) | [19.9](/filings/0001730168-24-000099.md) | [19.6](/filings/0001730168-25-000121.md) | [21.0](/filings/0001730168-25-000021.md) | [22.2](/filings/0001730168-25-000064.md) | [25.0](/filings/0001730168-25-000098.md) | [31.6](/filings/0001730168-26-000080.md) | [32.1](/filings/0001730168-26-000016.md) | [42.2](/filings/0001730168-26-000054.md) | [52.2](/filings/0001730168-26-000080.md) |
| Total assets | $bn | [72.9](/filings/0001730168-24-000139.md) | [178](/filings/0001730168-24-000023.md) | [175](/filings/0001730168-24-000080.md) | [168](/filings/0001730168-24-000099.md) | [166](/filings/0001730168-25-000121.md) | [165](/filings/0001730168-25-000021.md) | [165](/filings/0001730168-25-000064.md) | [166](/filings/0001730168-25-000098.md) | [171](/filings/0001730168-26-000080.md) | [170](/filings/0001730168-26-000016.md) | [179](/filings/0001730168-26-000054.md) | [188](/filings/0001730168-26-000080.md) |
| Current liabilities | $bn | [7.4](/filings/0001730168-24-000139.md) | [20.4](/filings/0001730168-24-000023.md) | [20.2](/filings/0001730168-24-000080.md) | [19.2](/filings/0001730168-24-000099.md) | [16.7](/filings/0001730168-25-000121.md) | [20.9](/filings/0001730168-25-000021.md) | [20.6](/filings/0001730168-25-000064.md) | [16.7](/filings/0001730168-25-000098.md) | [18.5](/filings/0001730168-26-000080.md) | [16.9](/filings/0001730168-26-000016.md) | [18.9](/filings/0001730168-26-000054.md) | [20.8](/filings/0001730168-26-000080.md) |
| Total liabilities | $bn | [48.9](/filings/0001730168-24-000139.md) | [108](/filings/0001730168-24-000023.md) | [105](/filings/0001730168-24-000080.md) | [102](/filings/0001730168-24-000099.md) | [98.0](/filings/0001730168-25-000121.md) | [95.6](/filings/0001730168-25-000021.md) | [95.0](/filings/0001730168-25-000064.md) | [92.3](/filings/0001730168-25-000098.md) | [89.8](/filings/0001730168-26-000080.md) | [90.0](/filings/0001730168-26-000016.md) | [91.5](/filings/0001730168-26-000054.md) | [88.5](/filings/0001730168-26-000080.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [62.0](/filings/0001730168-26-000080.md) | [63.8](/filings/0001730168-26-000016.md) | [62.7](/filings/0001730168-26-000054.md) | [57.2](/filings/0001730168-26-000080.md) |
| Current portion of debt | $bn | [1.6](/filings/0001730168-24-000139.md) | [2.4](/filings/0001730168-24-000023.md) | [2.4](/filings/0001730168-24-000080.md) | [3.1](/filings/0001730168-24-000099.md) | [1.2](/filings/0001730168-25-000121.md) | [1.7](/filings/0001730168-25-000021.md) | [1.7](/filings/0001730168-25-000064.md) | [0.9](/filings/0001730168-25-000098.md) | [3.2](/filings/0001730168-26-000080.md) | [2.3](/filings/0001730168-26-000016.md) | [2.3](/filings/0001730168-26-000054.md) | [2.3](/filings/0001730168-26-000080.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | [0.0](/filings/0001730168-25-000098.md) | [4.0](/filings/0001730168-25-000021.md) | [3.9](/filings/0001730168-25-000064.md) | [0.5](/filings/0001730168-25-000098.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [24.0](/filings/0001730168-25-000121.md) | [70.3](/filings/0001730168-25-000098.md) | [70.0](/filings/0001730168-25-000098.md) | [65.7](/filings/0001730168-25-000098.md) | [67.7](/filings/0001730168-26-000080.md) | [69.8](/filings/0001730168-26-000080.md) | [69.6](/filings/0001730168-26-000080.md) | [73.3](/filings/0001730168-26-000080.md) | [81.3](/filings/0001730168-26-000080.md) | [79.9](/filings/0001730168-26-000080.md) | [87.7](/filings/0001730168-26-000080.md) | [99.7](/filings/0001730168-26-000080.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-29) | Q1 FY2024 (2024-02-04) | Q2 FY2024 (2024-05-05) | Q3 FY2024 (2024-08-04) | Q4 FY2024 (2024-11-03) | Q1 FY2025 (2025-02-02) | Q2 FY2025 (2025-05-04) | Q3 FY2025 (2025-08-03) | Q4 FY2025 (2025-11-02) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [4.8 d](/filings/0001730168-25-000121.md) | [4.8](/filings/0001730168-25-000021.md) | [4.6 d](/filings/0001730168-25-000064.md) | [5.0 d](/filings/0001730168-25-000098.md) | [5.6 d](/filings/0001730168-25-000121.md) | [6.1](/filings/0001730168-26-000016.md) | [6.6 d](/filings/0001730168-26-000054.md) | [7.2 d](/filings/0001730168-26-000080.md) | [7.7 d](/filings/0001730168-25-000121.md) | [8.3](/filings/0001730168-26-000016.md) | [10.5 d](/filings/0001730168-26-000054.md) | [14.2 d](/filings/0001730168-26-000080.md) |
| Capital expenditure | $bn | [0.1 d](/filings/0001730168-25-000121.md) | [0.1](/filings/0001730168-25-000021.md) | [0.1 d](/filings/0001730168-25-000064.md) | [0.2 d](/filings/0001730168-25-000098.md) | [0.1 d](/filings/0001730168-25-000121.md) | [0.1](/filings/0001730168-26-000016.md) | [0.1 d](/filings/0001730168-26-000054.md) | [0.1 d](/filings/0001730168-26-000080.md) | [0.2 d](/filings/0001730168-25-000121.md) | [0.3](/filings/0001730168-26-000016.md) | [0.2 d](/filings/0001730168-26-000054.md) | [0.5 d](/filings/0001730168-26-000080.md) |
| Dividends paid | $bn | [1.9 d](/filings/0001730168-25-000121.md) | [2.4](/filings/0001730168-25-000021.md) | [2.4](/filings/0001730168-25-000064.md) | [2.5](/filings/0001730168-25-000098.md) | [2.5 d](/filings/0001730168-25-000121.md) | [2.8](/filings/0001730168-26-000016.md) | [2.8](/filings/0001730168-26-000054.md) | [2.8](/filings/0001730168-26-000080.md) | [2.8 d](/filings/0001730168-25-000121.md) | [3.1](/filings/0001730168-26-000016.md) | [3.1](/filings/0001730168-26-000054.md) | [3.1](/filings/0001730168-26-000080.md) |
| Share repurchases | $bn | [0.1 d](/filings/0001730168-25-000121.md) | [7.2](/filings/0001730168-25-000098.md) | [0.0 d](/filings/0001730168-25-000064.md) | [0.0 d](/filings/0001730168-25-000098.md) | [0.0 d](/filings/0001730168-25-000121.md) | [0.0](/filings/0001730168-26-000016.md) | [2.5](/filings/0001730168-26-000054.md) | [0.0 d](/filings/0001730168-26-000080.md) | [0.0 d](/filings/0001730168-25-000121.md) | [7.9](/filings/0001730168-26-000016.md) | [0.6](/filings/0001730168-26-000054.md) | [0.0 d](/filings/0001730168-26-000080.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-29) | Q2 FY2023 (2023-04-30) | Q3 FY2023 (2023-07-30) | Q1 FY2024 (2024-02-04) | Q2 FY2024 (2024-05-05) | Q3 FY2024 (2024-08-04) | Q1 FY2025 (2025-02-02) | Q2 FY2025 (2025-05-04) | Q3 FY2025 (2025-08-03) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [429](/filings/0001730168-24-000023.md) | [427](/filings/0001730168-24-000080.md) | [4,269](/filings/0001730168-24-000099.md) | [4,666](/filings/0001730168-25-000021.md) | [4,799](/filings/0001730168-25-000064.md) | [4,663](/filings/0001730168-25-000098.md) | [4,836](/filings/0001730168-26-000016.md) | [4,826](/filings/0001730168-26-000054.md) | [4,860](/filings/0001730168-26-000080.md) | [4,888](/filings/0001730168-26-000016.md) | [4,876](/filings/0001730168-26-000054.md) | [4,887](/filings/0001730168-26-000080.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,773,629,865 at 2026-08-28, from the cover of the [10-Q filed 2026-09-10](/filings/0001730168-26-000080.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.